USPTO serial 87547085
BOSTON CLINICAL RESEARCH INSTITUTE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 6, 2018
- Examiner
- BLANDU, FLORENTINA
- Law office
- TMO LAW OFFICE 117
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with BOSTON CLINICAL RESEARCH INSTITUTE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Boston Clinical Research Institute, LLC
Newton Center, MA
Other trademarks owned by Boston Clinical Research Institute, LLC
Boston Clinical Research Institute, LLC
Newton Center, MA
Other trademarks owned by Boston Clinical Research Institute, LLC
Boston Clinical Research Institute, LLC
Newton Center, MA
Other trademarks owned by Boston Clinical Research Institute, LLC
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kenneth R. L. Parker
Kenneth R. L. Parker Parker Key Law LLC343 Washington Street, Suite 200NEWTON, MA 02458UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Compiling and analyzing statistics, data and other sources of information for business purposes; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs | ACTIVE | Nov 10, 2008 |
| 042 | Clinical research in the field of electrocardiogram (EKG) analysis, Holter monitoring, coronary and peripheral arteriograms and angiogensesis, magnetic resonance imaging (MRI) and cardiac magnetic resonance (CMR) analysis, coronary computed tomography (CT) analysis, echocardiography analysis, intravascular ultrasound (IVUS) analysis, venographic and peripheral ultrasound analysis, and chest CT analysis; Data mining; Laboratory services, namely, imaging core lab services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials | ACTIVE | Nov 10, 2008 |
| 044 | Health assessment services; Medical ultrasound imaging services | ACTIVE | Nov 10, 2008 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Boston Clinical Research Institute, LLC
- Other trademarks owned by Boston Clinical Research Institute, LLC
- Other trademarks owned by Boston Clinical Research Institute, LLC
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named BOSTON CLINICAL RESEARCH INSTITUTE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 7, 2023 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Nov 7, 2023 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Nov 7, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 9, 2023 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Apr 10, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 10, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 10, 2023 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Apr 10, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 10, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 10, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 6, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 6, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 19, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 19, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 29, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 12, 2017 | ALIE | ASSIGNED TO LIE | — |
| Oct 31, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 31, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 31, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 31, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 31, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 30, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 2, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 1, 2017 | NWAP | NEW APPLICATION ENTERED | — |